Three cases of alopecia following clinical islet transplantation

American Journal of Transplantation

Volumn 11, Issue 1, 2011, Pages 163-168

  Zuk, D M ^a,b   Koh, A ^a,c   Imes, S ^a   Shapiro, A M J ^a,c   Senior, P A ^a,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ALBERTA HEALTH SERVICES   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Autoimmunity; islet transplantation; lymphopenia; mycophenolate mofetil; sirolimus; tacrolimus

Indexed keywords

CORTISONE; CYCLOSPORIN A; DACLIZUMAB; DITHRANOL; ETANERCEPT; INFLIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; SALICYLIC ACID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACNE; ADULT; ALOPECIA AREATA; ARTICLE; AUTOIMMUNITY; CASE REPORT; DIARRHEA; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDEMA; FATIGUE; FEMALE; GRAFT FAILURE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; OVARY CYST; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

ALOPECIA; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS TRANSPLANTATION; MIDDLE AGED;

EID: 78650853604     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03348.x     Document Type: Article

References (24)

1. Roep BO,. Islet autoreactive CD8 T-cells in type 1 diabetes: Licensed to kill? Diabetes 2008; 57: 1156-1157.
2. Shapiro AM, Lakey JR, Ryan EA, et al,. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238.
3. Ryan EA, Shandro T, Green K, et al,. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 2004; 53: 955-962.
4. Walter M, McDonald CG, Paty BW, Shapiro AM, Ryan EA, Senior PA,. Prevalence of autoimmune diseases in islet transplant candidates with severe hypoglycaemia and glycaemic lability: Previously undiagnosed coeliac and autoimmune thyroid disease is identified by screening. Diabet Med 2007; 24: 161-165.
5. Koh A, Imes S, Kin T, et al,. Supplemental islet infusions restore insulin independence after graft dysfunction in islet transplant recipients. Transplantation 2010; 89: 361-365.
6. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J,. Alopecia areata update: Part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 2010; 62: 177-188, quiz 189- 190.
7. Ferrando J, Grimalt R,. Partial response of severe alopecia areata to cyclosporine A. Dermatology 1999; 199: 67-69.
8. Shapiro R, Fung JJ, Jain AB, Parks P, Todo S, Starzl TE,. The side effects of FK 506 in humans. Transplant Proc 1990; 22: 35-36.
9. Tricot L, Lebbe C, Pillebout E, Martinez F, Legendre C, Thervet E,. Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients. Transplantation 2005; 80: 1546-1549.
10. Ushigome H, Yoshimura N, Okamoto M, et al,. Two cases of tacrolimus-induced alopecia following kidney transplantation. Transplant Proc 1999; 31: 2885-2886.
11. Talbot D, Rix D, Abusin K, Mirza D, Manas D,. Alopecia as a consequence of tacrolimus therapy in renal transplantation. Transplantation 1997; 64: 1631-1632.
12. Fink J, Flasar M, Harrington J, Weir M, Bartlett S,. Alopecia totalis related to tacrolimus use following kidney and pancreas transplantation [abstract presented at AST 1998]. 1998 [cited 2010 May 12 2010]; Available from
13. Kim BJ, Min SU, Park KY, et al,. Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata. J Dermatolog Treat 2008; 19: 216-220.
14. Teshima H, Kihara H, Nakagawa T, Hori Y,. Effective therapy with low dose of oral cyclosporine A and prednisolone for alopecia universalis. Arerugi 1990; 39: 714-717.
15. Teshima H, Urabe A, Irie M, Nakagawa T, Nakayama J, Hori Y,. Alopecia universalis treated with oral cyclosporine A and prednisolone: Immunologic studies. Int J Dermatol 1992; 31: 513-516.
16. Gupta AK, Ellis CN, Cooper KD, et al,. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis. J Am Acad Dermatol 1990; 22 (2 Pt 1): 242-250.
17. Shapiro J, Lui H, Tron V, Ho V,. Systemic cyclosporine and low-dose prednisone in the treatment of chronic severe alopecia areata: a clinical and immunopathologic evaluation. J Am Acad Dermatol 1997; 36: 114-117.
18. Price VH, Willey A, Chen BK,. Topical tacrolimus in alopecia areata. J Am Acad Dermatol 2005; 52: 138-139.
19. Thiers BH,. Topical tacrolimus: Treatment failure in a patient with alopecia areata. Arch Dermatol 2000; 136: 124.
20. Chen CH, Wen MC, Cheng CH, et al,. Infectious alopecia in a dog breeder after renal transplantation. J Chin Med Assoc 2008; 71: 477-480.
21. Posten W, Swan J,. Recurrence of alopecia areata in a patient receiving etanercept injections. Arch Dermatol 2005; 141: 759-760.
22. Anderson C, Uwiera R, Thangavelu G,. PD-1 expression is required in recent thymic emigrants to establish systemic self-tolerance. J Immunol 2010; 184 (meeting abstracts 1): 143.15.
23. Truong W, Hancock WW, Plester JC, et al,. BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice. J Leukoc Biol 2009; 86: 41-51.
24. Coles A, Deans J, Compston A,. Campath-1H treatment of multiple sclerosis: Lessons from the bedside for the bench. Clin Neurol Neurosurg 2004; 106: 270-274.